XHXuelei Hu

Xuelei Hu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xuelei Hu has a total of 34 co-authors. Here are the top co-authors by number of shared publications:

  • Tong Liu

    Key Laboratory of Green Chemical Process of Ministry of Education, Hubei Key Laboratory of Novel Reactor and Green Chemical Technology, School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan, China

    5 shared publications
  • Yao Wang

    School of Power and Mechanical Engineering, Wuhan University, Wuhan 430072, China

    3 shared publications
  • Anqi Xu

    Key Laboratory of Green Chemical Process of Ministry of Education, Hubei Key Laboratory of Novel Reactor and Green Chemical Technology, School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan, China

    2 shared publications
  • Biyu Zhang

    Key Laboratory of Green Chemical Engineering Process of Ministry of Education, Hubei Key Laboratory of Novel Reactor and Green Chemical Technology, School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan, China

    2 shared publications
  • Dong Zhang

    School of Power and Mechanical Engineering, Wuhan University, Wuhan, China

    2 shared publications
  • Jing Wang

    Key Laboratory of Green Chemical Process of Ministry of Education, Hubei Key Laboratory of Novel Reactor and Green Chemical Technology, School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan, China

    2 shared publications

Latest Publications

  • Open Access

    Nanocarriers based therapy and diagnosis of brain diseases: cross the blood-brain barrier

    by Lijun An, Jinwei Zhang, Xiaobo Wang, Yuanyuan Ge, Kunhui Sun, Junlin Dong, Ping Wang, Wei Li, Meifang Li, Xuelei Hu, et al.

    The blood-brain barrier (BBB) is the protective interface that isolates the central nervous system from circulating blood, which restricts approximately 98% of small molecule drugs and nearly all large molecules from entering the brain. Current methods to bypass the BBB, such as laser-guided interstitial thermal therapy and magnetic resonance guided focused ultrasound, are fraught with risks like impairing BBB integrity and brain damage, and are not suitable for long-term treatment. Nanocarriers have emerged as promising tools due to their ability to enhance drug delivery across the BBB while minimizing systemic toxicity. These nanocarriers leverage mechanisms including receptor-mediated, carrier-mediated, cell mediated and extra-stimuli mediated transport to improve BBB traverse and brain targeting. The review evaluates these strategies separately, discussing their potential and limitations for clinical application, and highlights recent advancements in integrating and optimizing nanocarriers utilizing synergistic strategies for the treatment and diagnosis of neurological disorders, including tumors, Alzheimer’s disease, Parkinson’s disease, and brain infections.


  • Manipulating the metal–oxygen covalency through diminishing d‐p band center difference for rechargeable zinc‐air batteries

    by De‐Xuan Huang, Jian‐Wei Zhao, Xue‐Lei Hu, Tong Liu

    Transition metal oxides have garnered significant attention as electrocatalysts for the oxygen reduction reaction (ORR) and the oxygen evolution reaction (OER). However, their sluggish reaction kinetics and poor stability hinder commercial applications. Herein, we report the synthesis of a bimetallic cobalt manganese oxide, Co 0.99 Mn 2.01 O 4 (CMO), synthesized via a hydrothermal technique, which serves as a highly efficient bifunctional ORR/OER electrocatalyst owing to its impressive half‐wave potential of 0.767 V and low overpotential of 1.677 V at 10 mA cm −2 . Theoretical calculations revealed that the d‐band centers of Co 3d and Mn 3d in CMO, located at tetrahedral and octahedral sites, are positioned near the Fermi level, facilitating the adsorption of electrocatalytic intermediates. Furthermore, the distance between the Co 3d and O 2p band centers in CMO is smaller than that in Co 3 O 4 , and the distance between the Mn 3d and O 2p band centers in CMO is shorter than that in Mn 2 O 3 , indicating that the Co–O and Mn–O bonds in CMO exhibit greater covalency, significantly enhancing ORR/OER activity. Notably, CMO serves as an advanced air electrode material for rechargeable zinc‐air batteries (ZABs), demonstrating improved charge–discharge performance with a low voltage gap of 0.87 V at 5 mA cm −2 , high peak power density of 124 mW cm −2 , and excellent cycle stability of over 540 h at 5 mA cm −2 . This superior ORR/OER activity, combined with the simple material combination, makes CMO a promising catalyst for rechargeable ZABs.


  • Open Access

    Network-based analysis and experimental validation of identified natural compounds from Yinchen Wuling San for acute myeloid leukemia

    by Biyu Zhang, Denggang Fu, Xin Wang, Xuelei Hu

    Objective: Traditional Chinese medicine (TCM) has garnered attention for its potential in cancer therapy. Yinchen Wuling San (YWLS), a classical herbal formula, has been traditionally used for liver-related conditions, but its bioactive components and molecular mechanisms relevant to hematologic malignancies such as acute myeloid leukemia (AML) remain unclear. This study aims to identify the active compounds and potential molecular targets of Yinchen Wuling San in the context of AML through network pharmacology analysis, and to experimentally validate the effects of selected candidate compounds in AML models.Methods: Active ingredients from six YWLS herbs were screened via the TCMSP database using oral bioavailability ≥30% and DL ≥0.18 thresholds. Targets were predicted using SwissTargetPrediction, and AML-related genes were obtained from DisGeNET and GeneCards. Key overlapping targets were analyzed via STRING PPI networks and GO/KEGG enrichment. Molecular docking was performed between three core compounds (genkwanin, isorhamnetin, quercetin) and hub proteins (e.g., SRC) using Sybyl-X. ADME profiles were predicted using SwissADME, and molecular dynamics simulations (GROMACS) assessed complex stability. These compounds were further evaluated in vitro (viability, apoptosis, cell cycle, RT-qPCR, flow cytometry) and in vivo using an AML xenograft mouse model.Results: Of 621 YWLS targets, 113 overlapped with 1,247 AML-related genes. PPI analysis identified hub genes, including AKT1, SRC, and EGFR. Enrichment analysis highlighted PI3K-AKT, MAPK, and JAK-STAT pathways. Genkwanin, isorhamnetin, and quercetin were predicted to target SRC, with strong molecular docking affinities. ADME analysis suggested favorable pharmacokinetics, and molecular dynamics simulations confirmed structural stability. In vitro, these compounds exhibited dose-dependent cytotoxicity, induced apoptosis, modulated the cell cycle, and downregulated SRC expression. Notably, Genkwanin promoted CD8+ T cell proliferation and inhibited leukemia growth, improving survival in a leukemia xenograft model.Conclusion: YWLS compounds, particularly Genkwanin, exhibit significant anti-leukemic activity via apoptosis induction, cell cycle modulation, and promote T cells proliferation. Genkwanin emerges as a promising therapeutic candidate for AML, warranting further clinical investigation.


  • Open Access

    Environmentally Friendly Biological Activated Carbon Derived from Sugarcane Waste as a Promising Carbon Source for Efficient and Robust Rechargeable Zinc–Air Battery

    by Lianghao Deng, Chenyang Wang, Anqi Xu, Fanglin Zha, Tong Liu, Xuelei Hu, Yao Wang

    China is one of the largest sugarcane industrial countries in the world, and the annual output of bagasse waste is abundant. Classical incineration, landfill, and other treatment methods are inefficient and seriously harmful to the environment, so it is urgent to develop a new comprehensive utilization of agricultural waste. In this work, the sugarcane waste residue is converted to biological activated carbon (BAC) through a simple pre-carbonization and KOH activation process, which is then mixed with perovskite oxide BaCo0.5Fe0.5O3−δ (BCF) to form BAC/BCF composite air electrode. BAC/BCF assembled rechargeable zinc–air battery (ZAB) exhibits a relatively good output maximum power density of 96 mW·cm−2 and considerable long-term charge–discharge cycle stability over 250 h operation. These results indicate that the BAC derived from sugarcane waste is a promising potential carbon material candidate for ZAB application, which can realize the high-value utilization of agricultural waste in the field of efficient and durable energy storage and conversion devices.


  • Compositional engineering of perovskite oxide BaCo0.5Fe0.5O3−δ as an efficient bifunctional electrocatalyst for rechargeable zinc–air batteries

    by Anqi Xu, Jian Zhou, Tong Liu, Jing Wang, Yao Wang, Dong Zhang, Dexuan Huang, Yilin Liu, Xuelei Hu

    Herein, a single-phase perovskite oxide BaCo0.5Fe0.5O3−δ (R-BCF) electrocatalyst has been successfully prepared for efficient and robust rechargeable zinc–air battery (ZAB) application by adapting a rapid cooling treatment at 300 °C min−1. Compared with the dual-phase electrocatalyst synthesized at a slow cooling rate of 3 °C min−1, the R-BCF electrocatalyst shows effectively improved oxygen reduction reaction and oxygen evolution reaction bifunctional electrocatalytic activity as well as greatly enhanced peak output power density of 132 mW cm−2 with an enhancement rate of 63%. Moreover, the R-BCF electrocatalyst-based ZAB demonstrates excellent electrocatalytic stability, and no obvious performance degradation is observed during the 210-hour operation with a total of 1260 charge–discharge cycles. These results indicate that the single-phase perovskite oxide R-BCF electrocatalyst is a potential bifunctional cathode alternative for efficient and stable ZAB application, and tuning the cooling rate can greatly manipulate the material composition for various energy storage and conversion devices.


  • Open Access

    Identification of Molecular Targets and Potential Mechanisms of Yinchen Wuling San Against Head and Neck Squamous Cell Carcinoma by Network Pharmacology and Molecular Docking

    by Biyu Zhang, Genyan Liu, Xin Wang, Xuelei Hu

    Head and neck squamous cell carcinoma (HNSCC) represents one of the most malignant and heterogeneous tumors, and the patients have low 5-year survival. Traditional Chinese medicine (TCM) has been demonstrated as an effective complementary and/or alternative therapy for advanced malignancies including HNSCC. It has been noted that several herbs that are used for preparing Yinchen Wuling San (YWLS) have anti-tumor activities, whereas their mechanisms of action remain elusive. In this study, network pharmacology and molecular docking studies were employed to explore the underlying mechanisms of action of YWLS against HNSCC. The 58 active ingredients from six herbs used for YWLS and their 506 potential targets were screened from the traditional Chinese medicine systems pharmacology database and analysis platform (TCMSP) and SwissTargetPrediction database. A total of 2,173 targets associated with HNSCC were mainly identified from the DisGeNET and GeneCards databases. An active components-targets-disease network was constructed in the Cytoscape. Top 20 hub targets, such as AKT1, EGFR, TNF, ESR1, SRC, HSP90AA1, MAPK3, ERBB2, and CCND1, were identified by a degree in the protein–protein interaction (PPI) network. Gene functional enrichment analysis showed that PI3K-AKT, MAPK, Ras, TNF, and EGFR were the main signaling pathways of YWLS in treating HNSCC. There were 48 intersected targets such as EGFR, AKT1, and TNF that were associated with patients’ outcomes by the univariate Cox analysis, and most of them had increased expression in the tumor as compared to normal tissues. The area under curves of receiver operating characteristic indicated their diagnostic potential. Inhibition of these survival-related targets and/or combination with EGFR or AKT inhibitors were promising therapeutic options in HNSCC. The partial active components of YWLS exhibited good binding with the hub targets, and ADME analysis further evaluated the drug-likeness of the active components. These compounds and targets identified in this study might provide novel treatment strategies for HNSCC patients, and the subsequent work is essential to verify the underlying mechanisms of YWLS against HNSCC.